INTRODUCTION
Secreted reporters in the blood or serum have been shown to be important tools for the detection, quantitation and noninvasive monitoring of different biological processes in experimental models [1] [2] [3] [4] [5] [6] [7] [8] . The most commonly used serum reporter is the secreted alkaline phosphatase or SEAP 2,3,5-7,9-13 . Normally, alkaline phosphatase is not secreted; however, Berger et al. 9 showed that placental alkaline phosphatase is expressed and released efficiently into the conditioned medium of mammalian cells that have been engineered to express this reporter. The level of SEAP in the conditioned medium is linearly related to the changes in its intracellular mRNA level as well as cell number 9, 10 . It is also possible to quantitatively detect SEAP in the serum of animals. In 1999, Abruzzese et al. 14 used the SEAP serum level to monitor the induction of gene expression followed by gene transfer to the muscles of adult mice. Since then, the SEAP reporter assay has been used as a surrogate serum marker to monitor different in vivo processes, including tumor growth and drug efficacy 3 , DNA vaccination 15 , promoter and transcription factors activation and inhibition 2, 6, 13 , viral gene transfer 16 , inflammatory events 7 , viral infection and replication 17 and endoplasmic reticulum stress 11 .
Recently, we have established a novel secreted reporter from the marine copepod Gaussia princeps named Gaussia luciferase or Gluc 1, 4, 8, 18, 19 . We have shown that this reporter is naturally secreted from mammalian cells in an active form and that the levels of Gluc in the conditioned medium are linear with respect to cell number, growth and proliferation 1, 19 . The Gluc reporter assay has been shown to be a sensitive reporter in monitoring endoplasmic reticulum stress and the secretory pathway 1, 4, 18, 20 , promoter activity 21 , small interference RNA silencing and micro-RNA biogenesis 22, 23 , as well as protein-protein interaction 24 . In vivo, the Gluc reporter assay has been used to localize tumors and to monitor tumor growth and proliferation using bioluminescence imaging 19, 25 . As Gluc is naturally secreted, we have shown that its level in the blood or urine can be used as a marker to monitor different in vivo biological events, such as tumor growth and response to therapy, viral infection and replication, as well as the viability of circulating cells 8 .
Advantages of using secreted reporter assays
In general, secreted reporters have several advantages over conventional methods for monitoring gene expression, such as bioluminescence imaging 26, 27 . In culture, secreted reporters can be quantified in the cell-free conditioned medium, avoiding the need for cell lysis and leaving the cells intact and available for confirmation analysis. In vivo, secreted reporters can be easily monitored in animals by withdrawing a few microliters of blood or urine and assaying for their activity, allowing real-time monitoring of in vivo processes. Although in vivo bioluminescence imaging has been successfully used in different fields 28 , including immunology 29 , oncology 30 , virology 31 and neuroscience 32 , this method requires expensive instrumentation (cooled couplecharged device (CCD) camera). In addition, this imaging technique is time consuming, involves frequent anesthesia and repeated systemic substrate injections and is limited by photon absorption by tissues as a function of depth 27 . These issues make it difficult to monitor relatively large cohorts of animals at small time intervals. around 6 d) (ref. 8); therefore, samples can be stored at 4 1C for several days without a significant change in Gluc reporter activity. In vivo, the Gluc reporter assay has several advantages over SEAP, which are presented in Table 1 .
Limitations of secreted reporter assays
In vivo, the SEAP reporter is assayed in serum, which requires that the samples are diluted and heat-deactivated to inhibit endogenous alkaline phosphatase activity before measurement using a plate reader. The linear range of the SEAP reporter assay is limited, which can depend on the efficiency of cell transduction and the amount of SEAP produced by the cells. On the other hand, the Gluc reporter reaction using the coelenterazine substrate has flash kinetics 19 ; therefore, a luminometer with a built-in injector is needed to perform the assay. As Gluc is very stable in the conditioned medium, a negative untreated cells control should always be included to which the results are normalized. However, this is not a problem in vivo, as the Gluc half-life in circulation is very short. The Gluc reporter assay is very sensitive, making it prone to pipetting errors. Using a larger assay volume (10-50 ml) can circumvent this problem, but care should be taken not to saturate the assay.
Experimental design
Plasmid or viral vectors expressing the reporter constructs (Gluc or SEAP). Initially, efficient gene transfer to the cells of interest needs to be accomplished. This can be performed using any DNA transfection reagent, such as Lipofectamine 2000 (see ref. 19 ). Alternatively, and more preferably, gene transfer using viral vectors, such as lentiviruses, can be used 8, 33, 34 . The advantage of lentivirus vectors is that they integrate the reporter transgene into the genome of cells, thus daughter cells inherit a copy of the reporter gene resulting in stable expression. This is particularly important when the biological process of interest needs to be monitored over a long period of time. In general, lentivirus vectors transduce many different cell types with high efficiency, including tumor cells and human stem cells. Furthermore, constructs that also express a fluorescent protein, such as GFP, are advantageous, as they allow easy monitoring of transduction efficiency by fluorescent microscopy. One way to express both the reporter (Gluc or SEAP) as well as GFP is to clone both of them into the same expression cassette in a lentivirus vector under the control of the constitutive cytomegalovirus (CMV) promoter separated by an internal ribosomal entry site elements 1 . A detailed protocol for the preparation of lentivirus vectors is described in Nature Protocols 34 . On the other hand, one might choose to subclone the Gluc or SEAP reporter into a viral vector, which is already used in a reader's own laboratory and will efficiently transduce the specific cell type that they are interested in. For optimization of the Gluc assay presented here, a lentivirus vector expressing both the Gluc and the blue fluorescent protein, cerulean (CFP), separated by an internal ribosomal entry site under the control of CMV promoter was used 1 . For SEAP assays, a similar lentivirus vector was used, which expresses both SEAP and the red-fluorescent protein, mCherry, under the control of CMV promoter 8 .
Transduction of cells to express the reporter. Cells of interest are transduced with the viral vector and are propagated in cell-specific growth media. In general, many human tumor cell lines, including Gli36 and U87 cells, as well as the commonly used 293T human fibroblast cells, are propagated in Dulbecco's modified Eagle medium (DMEM) high-glucose media supplemented with 10% (vol/vol) fetal bovine serum (FBS) and 1% (vol/vol) penicillin/ streptomycin (pen/strep). Transduced cells are plated into triplicate wells of a 24-well plate, at around 20% confluence. An aliquot of the conditioned medium is assayed for the reporter activity (Gluc or SEAP as in Boxes 1 or 2, respectively) (5-50 ml) at different time points (12, 24, 48 , 72 h) to confirm that stable transduction of the viral vector was achieved and that the reporter activity is linear with respect to time, i.e., cell growth and proliferation. This is particularly important when using SEAP, as it does not have a wide linear range with respect to cell number 1, 8 . When low signals are observed, possibly due to inefficient gene transfer, the experiment can be scaled up by assaying larger volumes of conditioned medium. Similarly, if the signals obtained are too high, which is possible for Gluc with high gene transfer, the experiment can be scaled down by diluting the conditioned medium in growth media (10Â) before assaying for Gluc activity.
Choice of cell lines. For optimization of the Gluc and SEAP assays, we used Gli36 human glioma cells, which infect very well (490%) with lentivirus vectors 8 . The doubling time for Gli36 cells is around 24 h, which leads to doubling of the reporter level over this period. In vivo, these cells form tumors rapidly, which grow exponentially over time 8, 19, 35 . On the other hand, the transfection efficiency of Gli36 cells with reagents, such as Lipofectamine 2000, is very low (o20%). When a viral vector is not available and transient gene transfer is needed, cell lines that are easily transfectable (e.g., 293T cells; 460%) should be used 1 Secreted reporter assays in culture. The biological process of interest should be monitored in culture in vitro first before moving to a more complex in vivo system. For instance, when monitoring a novel tumor therapeutic drug, the cells expressing the reporter should be plated into 24-well plates at 50-80% confluence and treated with the drug of interest. It is important to include negative controls of growth media alone as well as cells cultured with the diluent of the drug (vehicle) at the same concentration used in the experimental wells. It is always ideal to include a positive control (if available), which could be a drug known to kill the cells in the same mechanism as the drug of interest. Aliquots of the conditioned medium are assayed for the reporter activity at different time points. The results should always be normalized to the negative control treated with the vehicle. This protocol can be followed for any biological process, such as promoter activation, endoplamic reticulum stress and so on. If a lentivirus vector is unavailable and a transfection reagent is to be used for the reporter gene transfer, it is important to normalize for the transfection efficiency between different wells. If the reporter plasmid also expresses a fluorescent protein, such as GFP, it can be used for normalization using fluorescence microscopy followed by cell counting or fluorescence-activated cell sorting analysis 36 . Alternatively, and more quantitatively, cotransfection with another bioluminescent reporter that uses a different substrate, such as firefly luciferase (Fluc), can be performed. In this case, the cell lysates are analyzed at the end of the experiment for Fluc activity and the Gluc or SEAP reporter values are normalized to the Fluc values 1 .
Monitoring of in vivo processes. In general, athymic nude mice are used for tumor models and in vivo bioluminescence imaging. In our hands, Gluc can be expressed for at least 3 weeks in nonathymic wild-type mice without the signal being compromised due to the presence of neutralizing antibodies. For experiments that require longer monitoring of the Gluc signal in wild-type mice, one might want to initially test whether neutralizing antibodies affect the Gluc signal throughout the duration of the experiment. One way of achieving this is to inject (intravenous (i.v.)) 200 ml filtered conditioned medium from Gluc-expressing cells. The Gluc half-life in circulation is then monitored by collecting blood samples every 5 min for 1 h and measuring Gluc activity as described in Box 3 (see ref. 8 ). These injections are repeated twice per day over a 7-d period. Then, the injections are repeated once a week (for the duration of the experiment) followed by Gluc half-life measurement as above. In cases where antibodies have no effect on Gluc signal, the half-life of Gluc in circulation should remain the same (around 20 min).
The in vivo experiment is carried out in a manner similar to the in vitro assay described above. Mice are anesthetized with an intraperitoneal (i.p.) injection of ketamine/xylazine mixture, which provides a 100 mg per kg of body weight dose of ketamine and a 10 mg per kg of body weight dose of xylazine. Normally, for a 25-g mouse, 110 ml of anesthesia mixture (see REAGENT SETUP) is used. Initially, cells expressing the reporter are implanted into the location of interest. For tumor monitoring, the easiest model is to (18-25 1C) in the dark by wrapping the tube in aluminum foil to stabilize it. 2. Using a pipette, transfer 10-50 ml aliquot of the conditioned media to a well of a white or black 96-well plate. m CRITICAL STEP It is important to use white or black plates and not clear plates, as the bioluminescence signal can transfer from one well to the next leading to cross-contamination. 3. Measure the Gluc activity using a plate luminometer, which is set to inject 50 ml of 20 mM coelenterazine and to acquire photon counts for 10 s. 4. Analyze the data by plotting the relative light units ( y axis) with respect to either the cell number or time (x axis). In case that one is performing a dose-response curve, data can be plotted as % Gluc expression in which all data are compared with the control well, which is set to 100%. ? TROUBLESHOOTING BOX 2 | IN VITRO SEAP REPORTER ASSAY TIMING 1.5 H 1. Using the Great EscAPe SEAP assay kit (Clontech), mix 15 ml of cell-free conditioned medium with 45 ml of 1Â dilution buffer. 2. Incubate the mixture for 30 min at 65 1C.
3. Cool the sample to room temperature. 4. Add 60 ml of assay buffer containing L-homoarginine and incubate for 5 min at room temperature. 5. Add 60 ml of the chemiluminescent enhancer containing 1.25 mM CSPD substrate to the sample and incubate for 15 min at room temperature. 6. Transfer the reaction mixture to a clean white or black 96-well plate. m CRITICAL STEP It is important to use white or black plates and not clear plates, as chemiluminescence signals can transfer from one well to the next leading to cross-contamination. 7. Measure the chemiluminescence signal using a luminometer by acquiring photon counts for 5-10 s. 8. Analyze the data by plotting the RLU with respect to either cell number or time. In the case that one is performing a dose-response curve, data can be plotted as % SEAP expression in which all data are compared with the control well, which is set to 100%. inject the tumor cells subcutaneously 19 . In this case, B1 million cells (in 50 ml of phosphate-buffered saline (PBS)) are mixed with 50 ml of Matrigel (ice cold) and immediately implanted using an insulin syringe. A more complicated model would be to inject the cells in a biologically relevant environment, such as the brain, for gliomas 8 . Two controls are generally essential for the monitoring of in vivo processes: (i) blood or urine from mice that are not implanted with cells (background) and when evaluating the effects of drugs on tumorigenesis; and (ii) blood or urine from mice that are treated with the vehicle (the drug diluent; negative control). The time point at which to withdraw blood or urine will depend on the biological process of interest. For monitoring of tumor volume or circulating cell (such as stem cells and T lymphocytes) viability and proliferation, blood or urine can be withdrawn every 3 d over the course of a month and aliquots of whole blood/urine or serum are assayed for Gluc or SEAP activity, respectively. As an example, when monitoring the effect of a novel chemotherapeutic drug, tumor cells expressing the reporter are implanted subcutaneously. Blood or urine (5 ml) is withdrawn every 3 d and assayed for the reporter activity. Following tumor formation (around 2 weeks depending on the cell type used), different doses of the drug of interest are injected into the animal (i.v., i.p. or intratumoral, depending on the drug). Around five animals per drug dose should be used to obtain statistical significance. Blood, urine or serum samples are monitored for the reporter activity as described above for at least 1 month. If using Gluc as a blood or urine marker, the signal can be localized in the animal using in vivo bioluminescence imaging once a week. A similar protocol can be followed for monitoring of other biological processes, except that the time point at which blood, urine or serum is assayed for the reporter activity can be different and needs to be optimized for each process. For instance, endoplasmic reticulum stress is normally immediate after the treatment with thapsigargin, a known inducer of this type of stress 11 ; therefore, blood, urine or serum samples will be assayed every 1 h for the first 8-12 h post-treatment, and then again after 24 h.
In vivo Gluc bioluminescence imaging. Coelenterazine is normally injected intravenously at a dose of 4 mg per kg of body weight. For a 25-g mouse, 20 ml of 5 mg ml À1 coelenterazine is mixed with 130 ml of ice-cold PBS and injected intravenously immediately before imaging is performed. Injection through the tail vein is normally tricky; however, intraocular injections are normally much easier to perform and one might choose to inject the substrate this way. If this procedure is followed, some photons might be observed around the eye area, which can be due to the way the injection was performed; however, this is not usually detrimental to the experiment or the mice.
The SEAP assay. There are many kits available that measure the alkaline phosphatase activity. One kit that is used most is the Great EscAPe SEAP assay (Clontech). Another kit is the Phospha-Light SEAP reporter gene assay system (Applied Biosystems). Both of these kits basically use the same protocol. A homemade colorimetric SEAP assay system can also be prepared, although it will be much less sensitive (100-1,000-fold lower) than these kits (http:// home.ccr.cancer.gov/lco/ColorimetricSEAP.htm). 1. Withdraw 5 ml of blood by making a small incision in the tail of mice using a razor blade (no anesthesia required) or collect 5 ml of urine. 2. In the case of blood, immediately mix the sample with 1 ml of 50 mM EDTA (as an anticoagulant). 3. Prepare a solution of 100 mM coelenterazine by diluting it in PBS supplemented with 5 mM NaCl (pH 7.2). m CRITICAL STEP Incubate the coelenterazine mixture for 30 min at room temperature (18-25 1C) in the dark by wrapping the tube in aluminum foil to stabilize it. 4. Transfer 5 ml of blood or urine sample to a well of 96-well plate (white or black). m CRITICAL STEP It is important to use white or black plates not clear plates as the bioluminescence signal can transfer from one well to the next leading to cross-contamination. 5. Measure the Gluc activity using a plate luminometer, which is set to inject 100 ml of 100 mM coelenterazine and to acquire photon counts for 10 s. 6. Analyze the data by plotting the relative light units (RLU; y axis) with respect to time (x axis). In case that one is performing a drug treatment in vivo, data can be plotted as the percentage of photons in which all data are compared with the control group of animals, which is set to 100%. . A luminometer to monitor both the Gaussia luciferase and SEAP activity (EG&G Berthold Microlumat)
. Optional: a cooled CCD camera for in vivo bioluminescence imaging of Gluc (Xenogen)
REAGENT SETUP Lentivirus vectors Vectors are usually stored at À80 1C and they are stable for 2 years. Vectors should be thawed immediately before cell infection. Avoid freezing and thawing, as this will decrease the vector infection efficiency. ! CAUTION Use lentivirus vectors in a biological safety class 2 cabinet and wear appropriate personal protective clothing. Coelenterazine Coelenterazine is not soluble in aqueous solution. First, it should be dissolved in acidified methanol (add one drop of concentrated HCl to 10 ml of methanol) to a concentration of 5 mg ml À1 . Aliquots of 100 ml are stored at À80 1C, which is stable for 41 year. An aliquot that is used often can be stored at À20 1C. m CRITICAL Coelenterazine is prone to auto-oxidation, resulting in a decrease in signal over time. To stabilize this substrate, dilute it to a working concentration in DMEM and incubate for 30 min in the dark at 20-25 1C before use. PBS with 5 mM NaCl, pH 7.2, could be used as an alternative diluent for coelenterazine to give higher light output and more stability of the substrate. Anesthesia Prepare a mixture of ketamine and xylazine in saline solution by mixing two parts of ketamine (50 mg ml À1 ) with one part of xylazine (20 mg ml À1 ) and one part of 0.9% (wt/vol) NaCl. This mixture is stable at 20-25 1C indefinitely. ! CAUTION Harmful. Always wear gloves. Polybrene Dilute polybrene in sterile water to a final concentration of 8 mg ml À1 and store at 4 1C for a maximum of 12 months. Coelenterazine Prepare a solution of 5 mg ml À1 coelenterazine in acidified methanol, aliquot and store at À80 1C for a maximum of 2 years.
PROCEDURE Transduction of cells to express the reporter (Gluc or SEAP) TIMING 48-72 h
1| Plate the cells of interest, such as tumor cells, in a well of a 6-well plate in 2 ml of growth media (DMEM supplemented with 10% (vol/vol) FBS and 1% (vol/vol) Pen/Strep) at 70-80% confluence and incubate for 24 h in an incubator at 37 1C and 5% CO 2 .
2| Remove the media and wash the cells with 3 ml of PBS.
3| Transduce the cells with the appropriate construct. This can be done using option A using a lentivirus construct or option B using a plasmid construct. Remove the media from the cells and add the mix and incubate at 37 1C in a 5% CO 2 incubator for 4 h.
4|
Remove the media and wash the cells with 2 ml of PBS. Remove the PBS and add 2 ml of fresh culture medium and incubate the cells for a further 24 h.
5|
Determine the transduction/transfection efficiency by counting the number of GFP-positive cells using fluorescence microscopy in three different fields (Â10) normalized to the GFP-negative cells in the same fields. When the Gluc reporter plasmid or lentivirus vector does not contain an enhanced GFP expression cassette, transduction efficiency can be estimated by measuring 15-ml aliquots of the conditioned medium for Gluc or SEAP activity using the protocols described in Boxes 1 and 2, respectively. ' PAUSE POINT When using viral vectors that stably integrate into the host genome, such as lentiviruses, the cells may be grown and stored in liquid nitrogen indefinitely for later use.
Optimization of the linearity of the reporter assay with respect to time and cell number TIMING 48-72 h 6| Plate different amounts of cells (ranging from 10,000 to 100,000 cells) expressing the reporter construct in 0. 10| Remove the media and wash the cells with PBS as described in Step 4.
11| Prepare five different concentrations of the drug of interest in fresh media. Treat triplicate wells of cells with 0.5 ml of each drug concentration. Prepare three negative control wells by adding fresh media only and three vehicle control wells by adding media containing the drug diluent. m CRITICAL STEP Always include triplicate wells of cells treated with the drug diluent (vehicle) at the same concentration and volume of media used in the experimental wells as a negative control.
12| At different time points, remove 15 ml of the conditioned medium and assay for Gluc or SEAP reporter activity as described in Box 1 or Box 2, respectively. ' PAUSE POINT Aliquots of the conditioned medium may be stored at À20 or À80 1C and are stable for 41 month and can be assayed together at the last time point of the experiment. 16| Count the cells using a coulter counter or a hemacytometer.
17| Pellet the cells by centrifugation for 5 min at 1,500g at 20-25 1C.
18| Resuspend the cells in PBS, adjusting the concentration of the cells to 20,000 ml À1 .
19|
Anesthetize the mice by i.p. injection of a ketamine/xylazine mixture, which gives a ketamine dose of 100 mg per kg of body weight and xylazine dose of 10 mg per kg of body weight.
! CAUTION All animal studies should be carried out under institutional and national guidelines.
20| Implant the cells expressing the reporter in the location of interest or systemically intravenously depending on the biological process 8 . For a subcutaneous tumor model, mix 50 ml of ice-cold Matrigel with 50 ml of cells (1 million cells total) and implant them using an insulin syringe.
21|
Immediately before (time zero) and at different time points after cell implantation (once every 3 d for tumor growth), withdraw 5-10 ml of blood by simple tail-vein cut or collect a similar volume of urine and assay for the Gluc or SEAP reporter activity 8, 12 , as described in Boxes 3 and 4, respectively. 22| When the tumor is formed, generally after 1 week when using the Gli36 tumor cell line, divide the mice into groups (generally five mice per group) and inject intraperitoneally or intravenously with either the vehicle (negative control) or different doses of the drug of interest. The dose as well as the route of injection will depend on the drug used. m CRITICAL STEP It is essential to assay blood, urine or serum samples from mice that have not been impanted with any cells as a background control and from mice bearing reporter-expressing cells and treated with the vehicle as a negative control.
23| At different time points after treatment (once every 3 d for tumor therapy), withdraw 5-10 ml of blood by making a small incision in the tail of mice (no anesthesia required) or similar volume of urine and assay for Gluc or SEAP reporter activity as described in Boxes 3 and 4, respectively. ' PAUSE POINT Blood or urine aliquots (for Gluc) or serum (for SEAP) may be stored at À20 or À80 1C (stable for 1 month) and assayed for the reporter activity at a later time or together with samples collected at different time points.
24| Analyze the data by plotting the RLU on the y axis with respect to time on the x axis 8, 12 .
? TROUBLESHOOTING
In vivo Gluc bioluminescence imaging TIMING 30 min
25| Anesthetize the mice as described in Step 19.
26| Immediately before use, for each 25-g mouse, mix 20 ml of coelenterazine (5 mg ml À1 ) prepared in acidified methanol as described in REAGENT SETUP with 130 ml of cold PBS and inject immediately into the tail vein of mice or intraoccularly. ! CAUTION A small precipitate/cloudy solution might form during injection, which normally does not interfere with imaging. However, if coelenterazine diluted in PBS is incubated for a long period of time, a larger precipitate will form, which might lead to blood clots and death of the animal.
27| After coelenterazine injection, acquire photon counts over a 1-5 min period using a cooled CCD camera with no illumination 19 . m CRITICAL STEP As Gaussia luciferase reaction is fast with flash kinetics, it is important to image the animals immediately after coelenterazine injection. It is also essential to keep the time between each injection and the imaging constant. Normally, imaging is carried out 1 min after coelenterazine injection.
28| Take a light image of the animal in the chamber using dim polychromatic illumination 19 .
29| Process the images using an imaging program such as ImageJ (NIH; http://rsb.info.nih.gov/ij/) or other programs available from the supplier of the CCD camera.
30| Define the regions of interest around the tumor using an automatic intensity contour procedure to identify bioluminescence signals with intensities significantly greater than the background 19 .
31| Calculate the sum of the photon counts in these regions as a measurement of Gluc activity.
32| Fuse the bioluminescence images with the corresponding white light surface images in a transparent pseudocolor overlay to permit correlation of areas of bioluminescent activity with anatomy 19 .
33| Analyze the data by plotting the photons s À1 on the y axis with respect to time on the x axis 8, 19 . The number of cells in vivo is above the linear range of the reporter assay (especially for SEAP). System reached saturation Dilute the serum sample in the assay buffer (20-fold dilution rather then 4-fold) by mixing 2 ml of serum with 38 ml of assay buffer and proceed with the SEAP assay
ANTICIPATED RESULTS
In vitro detection of Gluc and SEAP reporter activity A linear curve with respect to cell number should be observed in cultured cells with both the Gluc and SEAP reporter assays (Fig. 1a) . Furthermore, a linear curve with respect to time as an index of cell growth and proliferation is expected with both reporters. Figure 1b shows the increase of Gluc expression with respect to time. A similar increase in SEAP expression would be expected (data not shown).
In vivo monitoring of tumor growth and proliferation using Gluc and SEAP reporter assays For both the SEAP and Gluc reporter, a linear curve is expected with respect to the number of cells expressing the reporter (Fig. 2a) . In the case of Gluc, similar linearity with respect to cell number is obtained using the urine assay (Fig. 2a) as well as an increase in photons with in vivo bioluminescence imaging (Fig. 2b) . The level of Gluc in the blood should increase over time indicating the growth of the tumor (Fig. 2c) . Upon treatment of tumors with drugs or viruses, the levels of Gluc in the blood should decrease, correlating with the efficiency of drug or virus treatment (Fig. 2c) .
Monitoring the Gluc and SEAP reporter activity of circulating cells Depending on the injected cell type, the results might vary. Initially, expect a high blood level of the reporter upon cell implantation. One to two days after implantation, the reporter activity should decrease signaling the death of some cells. At later time points, the signal is stable, indicating that some of the injected cells are still viable but not proliferating (Fig. 2d) ; the signal increases, indicating that the cells that survived the injection are proliferating; or the signal decreases to background levels, indicating that all of the implanted cells are dead. The expected results from the last 2 scenarios would be similar to the results presented in Figure 2c . 1.E + 06
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1.E + 00 Gluc signal was localized in the animals using a CCD camera and in vivo bioluminescence imaging. Gli36 cells (1 Â 10 6 ) expressing the Gluc reporter were implanted subcutaneously into nude mice (n ¼ 10). On day 10 after implantation, tumors were injected with either PBS (control, n ¼ 5) or an HSV oncolytic vector known to kill tumors (n ¼ 5). (c) Gluc reporter activity was monitored in the blood at different time points. C17.2 neuroprecursor cells (1 Â 10 6 ) expressing the Gluc reporter were injected intravenously into five nude mice, and Gluc activity in the blood was monitored over time. Data presented in c-d are from one representative mouse from each group with the experiment repeated 3Â. RLU, relative light unit. Modified with permission from Wurdinger et al. 8 .
